Cipesta Oral Suspension

Cipesta Oral Suspension – Broad-Spectrum Liquid Antibiotic

Cipesta Oral Suspension is a versatile fluoroquinolone antibiotic designed for patients who require a liquid alternative to solid tablets. In adults, it is indicated for a wide range of infections, including lower respiratory tract infections caused by Gram-negative bacteria and chronic suppurative otitis media. It is also highly effective for treating complicated urinary tract infections and several types of genital tract infections, such as gonococcal uretritis and pelvic inflammatory disease.

The suspension is a vital tool for managing gastrointestinal infections like traveler’s diarrhea and intra-abdominal infections. Clinically, it is also used for infections of the skin, soft tissues, bones, and joints. In pediatric populations, Cipesta is approved for specific conditions like kidney infections (pyelonephritis) and lung infections in children with cystic fibrosis. It also serves as a post-exposure prophylaxis for inhalational anthrax. The liquid format allows for precise dosing based on body weight, ensuring reliable therapeutic results for susceptible organisms.

• Treats respiratory, urinary, and gastrointestinal infections.
• Effective for skin, bone, joint, and pelvic infections.
• Approved for pediatric use in specific serious infections.
• Available as: Suspensions 125mg/5ml and 250mg/5ml.